Alginate-Derived Oligosaccharide Inhibits Neuroinflammation and Promotes Microglial Phagocytosis of β-Amyloid

Marine Drugs

Rui Zhou²  Xu-Yang Shi¹  De-Cheng Bi²  Wei-Shan Fang¹  Gao-Bin Wei¹  Xu Xu² 

[1] College of Life Science, Shenzhen Key Laboratory of Microbial Genetic Engineering, Shenzhen University, Shenzhen 518060, China; E-Mails:;Shenzhen Key Laboratory of Marine Bioresources and Ecology, Collage of Life Science, Shenzhen University, Shenzhen 518060, China; E-Mails:

关键词: alginate;    β-amyloid;    microglia;    neuroinflammation;    phagocytosis;    toll-like receptor 4;   

DOI  :  10.3390/md13095828

来源: mdpi

【 摘 要 】

Alginate from marine brown algae has been widely applied in biotechnology. In this work, the effects of alginate-derived oligosaccharide (AdO) on lipopolysaccharide (LPS)/β-amyloid (Aβ)-induced neuroinflammation and microglial phagocytosis of Aβ were studied. We found that pretreatment of BV2 microglia with AdO prior to LPS/Aβ stimulation led to a significant inhibition of production of nitric oxide (NO) and prostaglandin E₂ (PGE₂), expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) and secretion of proinflammatory cytokines. We further demonstrated that AdO remarkably attenuated the LPS-activated overexpression of toll-like receptor 4 (TLR4) and nuclear factor (NF)-κB in BV2 cells. In addition to the impressive inhibitory effect on neuroinflammation, we also found that AdO promoted the phagocytosis of Aβ through its interaction with TLR4 in microglia. Our results suggested that AdO exerted the inhibitory effect on neuroinflammation and the promotion effect on microglial phagocytosis, indicating its potential as a nutraceutical or therapeutic agent for neurodegenerative diseases, particularly Alzheimer’s disease (AD).

【 授权许可】

CC BY   
© 2015 by the authors; licensee MDPI, Basel, Switzerland.